|
1
|
Rademaker M: Isotretinoin: dose, duration
and relapse. What does 30 years of usage tell us? Australas J
Dermatol. 54:157–162. 2013. View Article : Google Scholar
|
|
2
|
Ward A, Brogden RN, Heel RC, Speight TM
and Avery GS: Isotretinoin. A review of its pharmacological
properties and therapeutic efficacy in acne and other skin
disorders. Drugs. 28:6–37. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Watkinson G and Akbar FA: Misoprostol in
peptic ulcer disease. Prostaglandins. 33:78–92. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Watkinson G, Hopkins A and Akbar FA: The
therapeutic efficacy of misoprostol in peptic ulcer disease.
Postgrad Med J. 64(Suppl 1): 60–77. 1988.PubMed/NCBI
|
|
5
|
Bleyer WA: The clinical pharmacology of
methotrexate: new applications of an old drug. Cancer. 41:36–51.
1978. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bonelli RM: Mifepristone (RU 486).
Diskussionsforum Med Ethik. XXXVIII–XLIII. 1992.(In German).
|
|
7
|
Grimes DA: Mifepristone (RU 486) for
induced abortion. Womens Health Issues. 3:171–175. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Goldzieher JW: Advances in oral
contraception. An international review of levonorgestrel and
ethinyl estradiol. J Reprod Med. 28(Suppl 1): 53–56.
1983.PubMed/NCBI
|
|
9
|
Fotherby K: Levonorgestrel. Clinical
pharmacokinetics. Clin Pharmacokinet. 28:203–215. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Goodman TA and Polisson RP: Methotrexate:
adverse reactions and major toxicities. Rheum Dis Clin North Am.
20:513–528. 1994.PubMed/NCBI
|
|
11
|
Erturan İ, Naziroǧlu M and Akkaya VB:
Isotretinoin treatment induces oxidative toxicity in blood of
patients with acne vulgaris: a clinical pilot study. Cell Biochem
Funct. 30:552–557. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Murakami Y, Sakauchi N, Ogasawara H,
Yamashita N, Masuda T and Tauchi K: A one-month repeated oral dose
toxicity study of methotrexate in unilaterally nephrectomized rats.
J Toxicol Sci. 23(Suppl 5): 681–699. 1998. View Article : Google Scholar
|
|
13
|
Kose F, Abali H, Sezer A, Mertsoylu H,
Disel U and Ozyilkan O: Little dose, huge toxicity: profound
hematological toxicity of intrathecal methotrexate. Leuk Lymphoma.
50:282–283. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tang OS, Xu J, Cheng L, Lee SW and Ho PC:
The effect of contraceptive pills on the measured blood loss in
medical termination of pregnancy by mifepristone and misoprostol: a
randomized placebo controlled trial. Hum Reprod. 17:99–102. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Harper C, Winikoff B, Ellertson C and
Coyaji K: Blood loss with mifepristone - misoprostol abortion:
measures from a trial in China, Cuba and India. Int J Gynaecol
Obstet. 63:39–49. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Prasad RN, Choolani M, Roy A and Ratnam
SS: Blood loss in termination of early pregnancy with mifepristone
and gemeprost. Aust N Z J Obstet Gynaecol. 35:329–331. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Aisien AO and Enosolease ME: Haemostatic
function in Norplant (levonorgestrel) users: a 3-year prospective
experience in Benin-City, Nigeria. Niger Postgrad Med J.
16:126–131. 2009.PubMed/NCBI
|
|
18
|
Karadag AS, Ertugrul DT, Tutal E and Akin
KO: Short-term isotretinoin treatment decreases insulin-like growth
factor-1 and insulin-like growth factor binding protein-3 levels:
does isotretinoin affect growth hormone physiology? Br J Dermatol.
162:798–802. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kindmark A, Rollman O, Mallmin H,
Petrén-Mallmin M, Ljunghall S and Melhus H: Oral isotretinoin
therapy in severe acne induces transient suppression of biochemical
markers of bone turnover and calcium hom eostasis. Acta Derm
Venereol. 78:266–269. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Milcan A, Colak M and Eskandari G:
Misoprostol enhances early fracture healing: a preliminary
biochemical study on rats. Bone. 41:611–613. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ettinger LJ: Pharmacokinetics and
biochemical effects of a fatal intrathecal methotrexate overdose.
Cancer. 50:444–450. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Perez C, Sutow WW, Wang YM and Herson J:
Evaluation of overall toxicity of high-dosage methotrexate
regimens. Med Pediatr Oncol. 6:219–228. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Castinetti F, Fassnacht M, Johanssen S,
Terzolo M, Bouchard P, Chanson P, Do Cao C, Morange I, Picó A,
Ouzounian S, et al: Merits and pitfalls of mifepristone in
Cushing’s syndrome. Eur J Endocrinol. 160:1003–1010. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jiang J, Lu J and Wu R: Mifepristone
following conservative surgery in the treatment of endometriosis.
Zhonghua Fu Chan Ke Za Zhi. 36:717–720. 2001.(In Chinese).
|
|
25
|
Purdie DW, Hay AW and Everett M: Short
term effects of SHD 386L and levonorgestrel on bone and mineral
metabolism in the postmenopause: a double-blind randomised
placebo-controlled trial. Maturitas. 14:189–199. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen C, Tian L, Zhang M, Sun Q, Zhang X,
Li X, Cao X, Liu Q, Li X and Hao L: Protective effect of amifostine
on high-dose methotrexate-induced small intestinal mucositis in
mice. Dig Dis Sci. 58:3134–3143. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
de Koning BA, Sluis M,
Lindenbergh-Kortleve DJ, Velcich A, Pieters R, Büller HA, Einerhand
AW and Renes IB: Methotrexate-induced mucositis in mucin
2-deficient mice. J Cell Physiol. 210:144–152. 2007. View Article : Google Scholar
|
|
28
|
Nakamaru M, Masubuchi Y, Narimatsu S,
Awazu S and Horie T: Evaluation of damaged small intestine of mouse
following methotrexate administration. Cancer Chemother Pharmacol.
41:98–102. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ramadan AA, Badr WY and Ali AM: The effect
of methotrexate (MTX) on the small intestine of the mouse. I A
macroscopic study. Folia Morphol (Praha). 36:68–78. 1988.
|
|
30
|
Baskerville A and Batter-Hatton D:
Intestinal lesions induced experimentally by methotrexate. Br J Exp
Pathol. 58:663–669. 1977.PubMed/NCBI
|
|
31
|
Tamura T, Yokoi R, Okuhara Y, Harada C,
Terashima Y, Hayashi M, Nagasawa T, Onozato T, Kobayashi K, Kuroda
J and Kusama H: Collaborative work on evaluation of ovarian
toxicity. 2) Two- or four-week repeated dose studies and fertility
study of mifepristone in female rats. J Toxicol Sci. 34 Suppl
1:SP31–SP42. 2009. View Article : Google Scholar : PubMed/NCBI
|
